DIVISLAB · Health Care · 2026-08-21

Divi's Laboratories Ltd

8.8★★★ PrimeStrong +13.2Stage 2 · wk 14In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹8,597
+0.32% today
₹2,28,223 Cr · Large cap
About this companyHealth Care· Labs & Life Sciences Services
Expand ▾

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Visit company website →
P/E (TTM)
70.4
Forward 48.1
Earnings Growth (YoY)
+13.6%
Revenue +9.5%
ROE
+16.2%
Profit margin +24.3%
Dividend Yield
0.44%
P/B 11.7
vs 52W High
-0.0%
₹5,689.5 lo₹8,600 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 14
1w13w26w
Week 14 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
29.3%
200 DMA: ₹6,650.8 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.41x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +8.3% vs MA50 +9.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #22 of 84 Stage 2 stocks in Health Care by RS.
Industry
Labs & Life Sciences Services
↑ Building
Stage 2%
33.3%
20d Δ
+16.7pp
1M return
+16.5%
3M return
+22.0%
Industry Stage-2 % · last 20 days
Ranks #1 of 2 Stage 2 stocks in this industry. Top stock in industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 19w
S2 37w
S3 14w
S2 14w
S2 14w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 3w → S2 19w → S3 9w → S2 9w → S3 3w → S4 5w → S1 2w → S2 37w → S3 14w → S2 14w → S3 7w → S4 2w → S3 1w → S2 11w → S3 2w → S4 13w → S1 2w → S2 14w current
Total tracked: 167 weeks across 18 stage runs.
1M
+17.7%
3M
+24.8%
6M
+39.8%
YTD
+34.5%
1Y
+40.9%
Scan Membership
Breakout Watch
Latest: 2026-05-19
4 appearances in last 60 days. First seen: 2024-05-16.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 14 · Vol —x
2026-08-20S2
Wk 14 · Vol —x
2026-08-19S2
Wk 13 · Vol —x
2026-08-18S2
Wk 13 · Vol —x
2026-08-17S2
Wk 13 · Vol —x
2026-08-14S2
Wk 13 · Vol —x
2026-08-13S2
Wk 13 · Vol —x
2026-08-12S2
Wk 12 · Vol —x
2026-08-11S2
Wk 12 · Vol —x
2026-08-10S2
Wk 12 · Vol —x
2026-08-07S2
Wk 12 · Vol —x
2026-08-06S2
Wk 12 · Vol —x
Sector Peers — Stage 2All →
ALIVUS
wk 19 · -3.4% from hi
9.0
NEULANDLAB
wk 12 · -1.5% from hi
9.0
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
MARKSANS
wk 13 · -3.5% from hi
8.4
Moving averages & range
50 DMA
₹7,451.6
200 DMA
₹6,650.8
52W High
₹8,600
52W Low
₹5,689.5
5D Low
₹8,481.5
Resistance levels (recent highs)
20d High
₹8,600
60d High
₹8,600
120d High
₹8,600
250d High
₹8,600
Next resistance
+0.0%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.